Our new unit at St George's Hospital is open for business

January 2004

8th January 2004Our new unit at St George's Hospital is open for businessThe opening of our second unit makes Richmond Pharmacology the largest phase I CRO in the UK. Our total capacity across the two sites has increased to 90 beds.The new unit is located in the Knightsbridge Wing of St George’s Hospital, Tooting, London. Situated within refurbished, access-controlled facilities and run by the same dedicated and highly trained team of over 80 staff already working at our Atkinson Morley’s Hospital Unit.We have made a further significant investment in our state of the art equipment with networked 12 lead Marquette ECGs at every bed.St George’s Healthcare Trust is one of the largest and busiest National Health Service Trusts in the country. As well as providing general and acute services, the hospital offers a range of specialist, teaching and research facilities with links to the services of St Georges Hospital Medical School.St George’s Hospital Medical School. The even closer proximity to the Medical School provides further opportunities for joint academic research, specialist studies or patient trials.Richmond Pharmacology’s new unit is one of the only commercial Phase I CROs with facilities located within the same site as both the Teaching Hospital and Medical School.To request a brochure on our new facilities or to arrange a site visit please contact Claire Tucker today.

Latest news

Upcoming Event

ACCP 2020, Translating Clinical Pharmacology Research into Patient-centered Care

21 - 23 September 2020
Dr. Jorg Taubel will be presenting posters that explore the subjects of cardiac health and diabetes.
View event

Richmond Pharmacology is delighted to confirm partnership with Intellia Therapeutics

October 20, 2020
Phase I study of Intellia Therapeutic’s NTLA-2001 for the treatment of hereditary transthyretin amyloidosis with polyneuropathy (hATTR-PN)
Read more

Richmond Pharmacology supports ReViral with the development of Sisunatovir

September 9, 2020
ReViral has confirmed the FDA has granted Fast Track designation to Sisunatovir.
Read more

Richmond Pharmacology helps UK patients gain early access to ultra-rare disease drug Lumasiran

August 17, 2020
Richmond Pharmacology early phase drug development update.
Read more